Humanized heart muscle

Patent metadata

Field	Value
Publication number	US-10897880-B2
Application number	US-201615739066-A
Country	US
Kind code	B2
Filing date	Jun 30, 2016
Priority date	Jun 30, 2015
Publication date	Jan 26, 2021
Grant date	Jan 26, 2021

Abstract

Described herein is a method for producing a chimeric non-human animal expressing a human NKX2-5, HANDII, TBX5 gene or a combination thereof gene comprising: a) generating a NKX2-5, HANDII, TBX5 or combination thereof null non-human animal cell, wherein both copies of the non-human NKX2-5, HANDII, TBX5 gene or combination thereof carry a mutation that prevents production of functional NKX2-5, HANDII, TBX5 protein or combination thereof in said non-human animal; b) creating a NKX2-5, HANDII, TBX5 or combination thereof null non-human blastocyst by somatic cell nuclear transfer comprising fusing a nucleus from said NKX2-5, HANDII, TBX5 or combination thereof null non-human animal cell of a) into an enucleated non-human oocyte and activating said oocyte to divide so as to form an NKX2-5, HANDII, TBX5 or combination thereof null non-human blastocyst; c) introducing human stem cells into the NKX2-5, HANDII, TBX5 or combination null non-human blastocyst of b); and d) implanting said blastocyst from c) into a pseudopregnant surrogate non-human animal to generate a chimeric non-human animal expressing human NKX2-5, HANDII, TBX5 or combination thereof.

First claim

What is claimed is:

1. A chimeric pig embryo comprising: (i) homozygous disruptions of endogenous NKX2-5, HANDII, and TBX5 genes in it genome, wherein said disruptions result in no expression of the endogenous NKX2-5, HANDII, and TBX5 proteins; and (ii) human cardiac cells expressing human NKX2-5, HANDII, and TBX5 proteins, wherein the human cardiac cells are differentiated from human pluripotent stem cells introduced into a pig embryo at an earlier stage of development than said chimeric pig embryo and wherein the introduced human pluripotent cells integrated into the inner cell mass of the pig embryo at the blastocyst stage.

2. A chimeric pig blastocyst comprising: (i) homozygous disruptions of endogenous NKX2-5, HANDII, and TBX5 genes in its genome, wherein said disruptions result in no expression of the endogenous NKX2-5, HANDII, and TBX5 proteins; and (ii) human pluripotent cells having intact NKX2-5, HANDII, and TBX5 genes, wherein the human pluripotent cells integrate into the inner cell mass of the blastocyst.

Assignees

• Univ Minnesota

Inventors

• Garry Daniel J
• Garry Mary G
• Koyano Naoko

Classifications

• A01K2217/00

  Genetically modified animals · CPC title

• A01K2267/025

  Animal producing cells or organs for transplantation · CPC title

• A01K2227/108

  Swine · CPC title

• A01K67/0271 Primary

  Chimeric vertebrates, e.g. comprising exogenous cells · CPC title

• C12N15/85 Primary

  for animal cells · CPC title